# Lancaster Colony Corporation (LANC) — Investment Thesis

**Exchange:** NASDAQ  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-28  
**Tier:** Free primer (steps 1 & 3 of 19)  
**Sibling pages:** /stocks/LANC/financials · /stocks/LANC/memo

> This page shows the free thesis context (business model + recent catalysts).
> The full investment thesis (moat analysis, DCF, scenarios, risk register) is available
> via GET /api/v1/research/LANC/memo ($2.00, Bearer token).

## Business Model

---
step: 01
title: Business Overview
ticker: LANC
current_ticker: MZTI
source: coverage-next-full
generated: 2026-05-28
---

### The Marzetti Company (LANC/MZTI) — Business Overview

#### Key Findings

- **Two-segment specialty food operator:** Retail (~53% FY25) sells owned and licensed branded dressings, frozen breads, and dips through grocery/mass; Foodservice (~47%) custom-formulates private-label sauces, dressings, and frozen breads for national chain restaurants [S3].
- **Brand portfolio anchored by category leaders:** Marzetti® (#1 refrigerated salad dressing), New York Bakery™ (#1 frozen garlic bread), Sister Schubert's® (#1 frozen yeast dinner roll); plus shelf-stable Cardini's®, Girard's®, Chatham Village® [S3].
- **Licensed restaurant-brand portfolio** unique in the category: exclusive retail license rights to Chick-fil-A®, Olive Garden®, Buffalo Wild Wings®, Texas Roadhouse®, Subway®, Arby's® sauces and breads [S3].
- **Customer concentration is structural:** Walmart 19% of consolidated sales, Chick-fil-A 29% (Retail license + Foodservice direct, combined) — both trending up, FY23→FY25 [S3].
- **Issuer identity:** Lancaster Colony Corp rebranded to The Marzetti Company effective Jul 1, 2025; CIK 0000057515 unchanged; sole asset class is the food business since the 1997–2014 divestiture of glass and candle units [S2][S3].

#### Implications for Thesis and Valuation

The business is a category-leadership compounder in narrow specialty niches, not a broad-based CPG. Two real strategic assets define the franchise: (1) the licensed-restaurant retail program — a hard-to-replicate moat anchored by the 20+ year Chick-fil-A relationship — and (2) Foodservice culinary R&D + scale that supports custom co-manufacturing for top QSR chains. The cost is concentration: Walmart + Chick-fil-A together are ~48% of revenue, which makes a single relationship rupture an existential thesis risk. Valuation should reflect both the durable category leadership (premium ROIC) and the concentration overhang (justifying a discount to lower-concentration peers).

#### Objective

Establish a clear picture of what the company does, how it makes money, what segments it reports, who its largest customers are, and what its key strategic assets are — so subsequent steps can reference this baseline.

#### Narrative Analysis

##### Corporate Identity and History
The Marzetti Company is an Ohio corporation founded in 1961 by John B. Gerlach as Lancaster Colony Corp; it was initially a diversified conglomerate (food + glass + candles) and progressively divested the non-food businesses through 2014. The Marzetti brand was acquired in 1969 and became the operational flagship; the 2025 rebrand simply unified the corporate identity around it [S3][S8]. CEO David Ciesinski has led the company since 2017; Executive Chairman John B. Gerlach Jr. (founder's grandson) has served since 2017 after a prior CEO tenure [S7].

##### Retail Segment (~53% of FY25 revenue, $1,010M run-rate)
Three product classes per the 10-K [S3]:
- **Shelf-stable dressings/sauces/croutons** — 23% of consolidated sales: includes Marzetti, Cardini's, Girard's, Chatham Village brands + licensed Olive Garden, Texas Roadhouse, Subway shelf-stable sauces.
- **Frozen breads** — 20%: New York Bakery garlic bread, Sister Schubert's yeast rolls, Texas Roadhouse frozen rolls (license).
- **Refrigerated dressings/dips/other** — 10%: Marzetti refrigerated, Marzetti Simply, Marzetti Protein, refrigerated dips, fruit dips.

Sold through grocery (Kroger, Albertsons, regional chains), mass (Walmart), club (Costco, Sam's), e-commerce. Top 5 Retail customers concentrate to 62% of segment FY25 (up from 59% FY24 and FY23) — consistent with US grocery consolidation [S3].

##### Foodservice Segment (~47% of FY25 revenue, $899M run-rate)
Two product classes per the 10-K [S3]:
- **Dressings & sauces** — 35% of consolidated sales: custom-formulated for Chick-fil-A, Olive Garden, Buffalo Wild Wings, Texas Roadhouse, Subway, Arby's.
- **Frozen breads & other** — 12%: frozen rolls and other items.

Supplied primarily via foodservice distributors (US Foods, Sysco, Performance Food Group), with limited direct supply to certain large accounts. Top 5 direct Foodservice customers = 53% of segment FY25.

##### Manufacturing and Operations
14 US food plants (recently augmented by the Winland Foods Atlanta sauce/dressing facility acquired Feb 2025 for $78.8M [S1][S3]). Most plants serve both segments. Recent operational themes: SAP S/4HANA Wave 1 went live Jul 2022; The Marzetti Way Optimization Plan launched FY24 (cost reduction + supply chain rationalization); ramping new dressings/sauces capacity at Horse Cave, KY.

##### Strategic M&A
- **Bachan's, Inc.** (Japanese BBQ sauce brand) — announced Mar 9, 2026; closed May 1, 2026; purchase price not yet disclosed (FY26 10-K expected late Aug 2026) [S4].
- **Winland Foods Atlanta facility** — closed Feb 2025; $78.8M cash; adds Foodservice sauce/dressing capacity [S1][S3].

##### Geographic Concentration
US-only operations. All 14 plants in US. Some third-party manufacturing in US, Canada, and Europe (limited). No foreign listings. Coverage Limitation does not apply.

#### Evidence and Sources

Sources detailed below; all on-disk in `LANC_financials/`. Customer concentration disclosures from FY25 10-K Item 1; segment revenue mix from 10-K Note 9 and Q3 FY26 8-K [S3][S4].

#### Assumption Register Updates

A05 (Retail share 53%), A06 (Chick-fil-A 29%), A07 (Walmart 19%) — all sourced to FY25 10-K disclosures. No new register entries from this step.

#### Tables and Calculations

##### FY25 Revenue Mix by Product Class (% of consolidated)

| Class | Segment | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Shelf-stable dressings/sauces/croutons | Retail | 23% | 23% | 23% |
| Frozen breads | Retail | 20% | 19% | 19% |
| Refrigerated dressings/dips/other | Retail | 10% | 11% | 11% |
| Dressings & sauces | Foodservice | 35% | 35% | 35% |
| Frozen breads & other | Foodservice | 12% | 12% | 12% |
| **Retail total** | | **53%** | **53%** | **53%** |
| **Foodservice total** | | **47%** | **47%** | **47%** |

##### Customer Concentration Trajectory

| Customer | FY23 | FY24 | FY25 |
|---|---|---|---|
| Walmart | 18% | 18% | 19% |
| Chick-fil-A (Retail license + FS, combined) | 26% | 28% | 29% |
| Top 5 Retail customers (% of Retail) | 59% | 59% | 62% |
| Top 5 Foodservice direct customers (% of Foodservice) | 58% | 53% | 53% |

Customer concentration is trending up; Chick-fil-A particularly notable [S3].

##### Brand Portfolio Quick Map

| Brand | Type | Category | Position |
|---|---|---|---|
| Marzetti® / Marzetti Simply™ | Owned | Refrigerated dressings, dips | #1 refrigerated dressing |
| New York Bakery™ | Owned | Frozen garlic bread | #1 frozen garlic bread |
| Sister Schubert's® | Owned | Frozen yeast rolls | #1 frozen yeast dinner roll |
| Cardini's® | Owned | Shelf-stable dressings (Caesar) | Premium niche |
| Girard's® | Owned | Shelf-stable dressings | Premium niche |
| Chatham Village® | Owned | Croutons | Top-3 category |
| Chick-fil-A® | Licensed (retail) | Sauces, dressings | Exclusive license |
| Olive Garden® | Licensed (retail) | Dressings | Exclusive license |
| Buffalo Wild Wings® | Licensed (retail) | Sauces | Exclusive license |
| Texas Roadhouse® | Licensed (retail) | Steak sauces, frozen rolls | Exclusive license |
| Subway® | Licensed (retail) | Sauces | Exclusive license |
| Arby's® | Licensed (retail) | Sauces | Exclusive license |

#### Open Questions and Data Gaps

- Bachan's purchase price not yet disclosed; will appear in FY26 10-K (Aug 2026 expected) — affects Step 07 and revenue/EPS forecast for FY27.
- License agreement terms (durations, exclusivity scope, royalty structure) are not publicly itemized — material to moat durability assessment in Step 10.
- Foodservice direct vs. distributor revenue split is not separately disclosed.

#### Next-Step Dependencies

Step 02 (Industry & Market) and Step 03 (Revenue Architecture) will deepen the segment and customer-concentration analysis using the brand portfolio and the peer set from `LANC_peer_universe.md`. Step 10 (Moat) will return to the licensed-restaurant program as the central moat hypothesis.

#### Source Index

See Step 00 source index; all references [S1]–[S8] inherited verbatim. No new sources added in Step 01.

## Recent Catalysts

---
step: 12
title: Catalysts (Bull and Bear)
ticker: LANC
current_ticker: MZTI
source: coverage-next-full
generated: 2026-05-28
---

### Step 12 — Catalysts (Bull and Bear)

#### Key Findings

- **Most important near-term catalyst: Q4 FY26 + full-year FY26 reported late Aug 2026** — will include ~2 months of Bachan's contribution, full-year Marzetti Way Optimization tracking, and disclosure of Bachan's purchase price (with implied ROIC) [S4].
- **Q3 FY26 Retail softness is the near-term overhang** — Retail −3.2% YoY; club channel + private label headwinds; needs Q4 stabilization to confirm thesis [S4].
- **Multiple expansion / "re-rating" catalysts** are mechanically large at current valuation: stock at 16x forward P/E vs. peer median ~18–20x = ~25% upside on multiple alone.
- **Bachan's deal is a TBD catalyst** with both bull (clean-label sauce platform, accretion) and bear (price discipline question) angles.
- **Special dividend possibility:** With M&A pipeline less visible post-Bachan's, the company may consider a special dividend in FY26/FY27 — would be a clear positive catalyst.

#### Implications for Thesis and Valuation

Near-term catalysts skew positive: Q4 FY26 results + Bachan's accretion + multiple re-rating + ongoing Foodservice momentum. Bear-case catalysts skew toward sector-wide pressure (GLP-1, RFK/HHS) and Q3 Retail softness extension. Step 14's valuation should weight a 65%/25%/10% bull/base/bear scenario distribution given the depth of the discount in current valuation. For Step 16, the Bachan's deal price disclosure is the single best near-term variant-perception test.

#### Objective

Identify upcoming catalysts (positive and negative) that will drive the equity over the next 6–18 months; surface the binary events that could materially move the thesis; calibrate the catalyst calendar.

#### Narrative Analysis

##### Near-Term Catalysts (next 6 months)

**Aug 2026 — FY26 Q4 + Full Year Earnings (10-K + 8-K):**
- Will include first 2 months of Bachan's contribution
- Discloses Bachan's purchase price (and therefore deal ROIC)
- Reports full-year FY26 segment performance — confirms or refutes Q3 Retail softness
- Initial directional commentary on FY27
- Likely to drive significant single-day price reaction (~5–10% magnitude)

**Sep–Oct 2026 — Annual Proxy Filing:**
- Updated NEO compensation reflecting FY26 outcomes
- Beneficial ownership tracking — has the Gerlach bloc materially changed?
- Director slate + governance discussion

**Nov 2026 — Q1 FY27 Earnings:**
- First full quarter with Bachan's (initial accretion signal)
- New CEO commentary on FY27 outlook
- Likely modest reaction (5–7%)

##### Medium-Term Catalysts (6–18 months)

**Late 2026 / Early 2027 — Possible Special Dividend Announcement:**
- Multi-year cash build + Bachan's deal closing reduces remaining M&A optionality
- Company has historic pattern of special dividends in low-M&A periods
- Would be a meaningful capital-return signal

**Feb 2027 — Q2 FY27 Earnings (Holiday Quarter):**
- The largest seasonality quarter; tests if Retail recovery is occurring
- Bachan's full Q2 contribution

**Aug 2027 — FY27 Annual Report:**
- Full year of Bachan's
- Marzetti Way Optimization tracking through full FY27
- Possible margin expansion validation

##### Catalyst Categories

**A. Operational Catalysts (Positive):**
- Foodservice growth acceleration: Chick-fil-A unit growth + new product co-development = ~5–7% segment growth
- Marzetti Way Optimization Plan margin expansion (GM 23.9% → 25–26%)
- Bachan's accretion: estimated ~+3–5% EPS contribution if deal economics are reasonable
- New plant + capacity utilization at Horse Cave KY ramping

**B. Capital Return Catalysts (Positive):**
- Regular dividend increases (annual cadence)
- Possible special dividend
- Modest buyback acceleration at sub-$120 stock (would be value-additive)

**C. Strategic Catalysts (Positive):**
- New retail license partnership (a major addition to the program would be transformational)
- Additional bolt-on M&A in clean-label specialty
- Bachan's category expansion (Costco rollout, etc.)

**D. Operational Catalysts (Negative):**
- Q4 FY26 Retail softness extension (worse than 9M FY26 trajectory)
- Foodservice slowdown if QSR traffic decelerates
- Bachan's integration friction (rare for clean bolt-on, but possible)

**E. Sector Catalysts (Negative):**
- RFK/HHS regulatory action on dyes, additives, ultra-processed labels
- GLP-1 penetration accelerating (current consultant estimates already 1–2% pa drag)
- Private-label intensification at Walmart/Costco

**F. Idiosyncratic Catalysts (Negative):**
- Loss of any major QSR partner (low probability, high severity)
- Major recall or food-safety incident
- Adverse Bachan's price disclosure (overpaid → multiple compression)

##### Catalyst Calendar

| Date | Event | Direction | Magnitude |
|---|---|---|---|
| Aug 2026 | FY26 10-K + Q4 8-K + Bachan's price | Mixed | High |
| Sep 2026 | Annual proxy | Neutral | Low |
| Nov 2026 | Q1 FY27 earnings | Positive | Med |
| Dec 2026 | Industry trade shows (PMA Fresh Summit etc.) | Neutral | Low |
| Q1 2027 | Possible special dividend announcement | Positive | Med-High |
| Feb 2027 | Q2 FY27 earnings (holiday quarter) | Positive | Med |
| May 2027 | Q3 FY27 earnings | Neutral | Med |
| Aug 2027 | FY27 10-K + Q4 | Positive | Med-High |

##### Variant Perception Anchor

The market is currently pricing Marzetti for low-single-digit growth + flat margins + no Bachan's accretion. The 16x forward P/E implies modest expectations. The variant perception that could deliver upside:
- Foodservice grows mid-single-digits, not low-single-digits
- Margin expands to 25%+ GM not 24%
- Bachan's accretive at ~3–5% to FY27 EPS
- Multiple re-rates to 18–20x peer median

Combined, the variant view supports ~+30–50% equity upside over 12–18 months without unusual operational outperformance.

#### Evidence and Sources

Q3 FY26 8-K segment commentary + Bachan's close [S4]; consensus PT $159 (~38% upside) + forward P/E 16.16x [S5]; FY25 10-K MD&A on Marzetti Way Optimization + capacity [S3]; industry tailwinds/headwinds [S9].

#### Assumption Register Updates

A19 (FY26E EPS $7.11), A20 (FY27E EPS $7.65–$8.00), A21 (what's priced in: flat-growth assumption) — all confirmed and serve as the variant perception anchor.

#### Tables and Calculations

##### 6–18 Month Catalyst Probability Map

| Catalyst | Probability | Direction | EPS Impact | Multiple Impact |
|---|---|---|---|---|
| FY26 Q4 / Bachan's price disclosure | 100% | Mixed | +/− 3% | +/− 1x P/E |
| Foodservice growth +5%+ FY27 | 60% | Positive | +5% | +2x P/E |
| Multiple re-rating to 18x | 40% | Positive | 0 | +12% price |
| Special dividend FY26/27 | 25% | Positive | 0 | +3–5% price |
| Loss of major QSR partner | 5% | Negative | −30% | −5x P/E |
| GLP-1 acceleration | 30% | Negative | −2% | −1x P/E |
| RFK/HHS direct action | 25% | Negative | −1% | −1x P/E |
| Recession / Foodservice slowdown | 25% | Negative | −10% | −1x P/E |

Probability-weighted: net upside catalyst tilt is ~+12–15% over 12–18 months, before any binary blow-out.

##### Multiple Re-Rating Math

At spot $114.93 / 16.16x forward P/E = $7.11 FY26E EPS:
- If FY27 EPS = $7.80 (midpoint of $7.65–$8.00)
- If multiple re-rates to peer median 18x: $7.80 × 18 = **$140 target (+22%)**
- If multiple re-rates to peer high 20x: $7.80 × 20 = **$156 target (+36%)**
- Consensus PT $159 = implies ~20x forward P/E — consistent with re-rating to peer high

For Step 14, the 18x P/E base case + $7.80 FY27E EPS ≈ $140 base-case fair value is internally consistent.

---

#### Bull Case — 3 Bullets

- **Foodservice momentum sustained:** Foodservice 9M FY26 +5% revenue / +20% op income is a structurally durable trend driven by Chick-fil-A unit growth + Olive Garden + Texas Roadhouse traffic. If the trajectory holds through FY27, blended Foodservice operating margin lifts toward 14–15% (vs. ~12% FY25), adding $20–30M of incremental op income on top of the base case.
- **Margin recovery to 25%+ GM:** The Marzetti Way Optimization Plan is delivering 50–100bps GM lift per year; combined with cycling out of commodity peak + ERP optimization, GM trajectory could reach 25–26% by FY28. At $1.9B+ revenue, that's $50–75M of incremental gross profit annually — meaningfully accretive to EPS.
- **Multiple re-rating + Bachan's accretion:** Stock at 16x forward P/E vs. peer median 18–20x = 12–25% multiple expansion alone. Add Bachan's contribution (estimated +3–5% to FY27 EPS) + special-dividend possibility, and the total 18-month return potential is 30–50%, supported by 3.5% dividend yield while waiting.

#### Bear Case — 3 Bullets

- **Customer concentration realizes:** Walmart partial de-shelving in dressings (1–2 SKUs lost to private label) + a Chick-fil-A licensing renegotiation pressures margins. Combined 5–10% revenue hit and 15–20% EPS hit. The Q3 FY26 Retail softness (−3.2% YoY) is the warning signal; if it extends into Q4 FY26 + FY27, the multiple compresses to peer-low ~13–14x P/E.
- **Sector headwinds compound:** RFK/HHS regulatory action on additives/dyes forces $5–15M reformulation cost + 100–200bps GM compression during transition. Combined with GLP-1 1–2% pa volume drag + accelerating private-label intrusion in dressings, the sector compresses ~$50–100M cumulative revenue over 3 years.
- **Bachan's overpaid + integration friction:** Bachan's purchase price (~$200M est) implies ~10–15x revenue for a sub-$30M revenue brand — on par with premium specialty CPG bolt-ons but expensive. If deal economics weaken (slower category growth, higher integration cost), the deal is dilutive in Years 1–2 and the company's M&A discipline reputation takes a hit. Stock could compress to 14x P/E ~$95–$100 target.

#### Open Questions and Data Gaps

- No formal management guidance — directional commentary only
- Bachan's purchase price will be disclosed Aug 2026 (10-K) — currently TBD
- Forward FY27 consensus rough; updated post-Bachan's close

#### Next-Step Dependencies

Step 16 (Variant Perception) will deepen the bull/bear analysis and produce a probability-weighted thesis. Step 18 (Portfolio Sizing) will use the catalyst calendar + bull/bear distribution to size the position.

#### Source Index

Inheriting [S1]–[S10]. No new sources added.

## Full Investment Thesis (Premium)

The full research tier adds these thesis-critical dimensions:

- Moat Analysis — durable competitive advantages, switching costs, network effects
- Investment Thesis — variant perception, what has to be true, why market may be wrong
- Bull / Base / Bear Scenarios — probability weights, catalysts, price targets
- Risk Register — macro, competitive, execution, regulatory risks with materiality ratings
- Management Quality — capital allocation track record, incentive alignment
- DCF Valuation — 10-year model with sensitivity matrix

**API endpoint:** GET /api/v1/research/LANC/memo

## Navigation

- Overview: /stocks/LANC
- Financials: /stocks/LANC/financials
- Thesis (this page): /stocks/LANC/thesis
- Investment Memo: /stocks/LANC/memo
- Coverage universe: /stocks